XXV (iPath Inverse S&P 500 VIX Short-Term Futures ETN)

XXV was a short VIX ETN by Barclays iPath. It ceased trading on 29 March 2018.

XXV Exposure and Basic Characteristics

XXV had been designed to track the inverse of S&P500 VIX Short-Term Futures Index (excess return) and therefore provided short volatility exposure on the short (near) end of the VIX futures curve.

XXV was much less liquid than other short VIX ETFs and ETNs like XIV (by VelocityShares, also already delisted) or SVXY (by ProShares, still trading).

Direction: Short, unleveraged

Underlying index: S&P500 VIX Short-Term Futures Index ER

Exposure: Short (negative position) in the short end (near term) of the VIX futures curve (short positions in the nearest and the second nearest VIX futures contract months, rolling to maintain constant 1 month maturity).

XXV options: Not available

Product type: ETN (exchange traded note)

Issuer: Barclays Bank PLC

Provider: Barclays iPath

Inception date: 16 July 2010

Closing date: 29 March 2018

The iPath Inverse S&P 500 VIX Short-Term Futures ETN is designed to provide investors with inverse exposure to the S&P 500 VIX Short-Term Futures™ Index Excess Return. ... The S&P 500 VIX Short-Term Futures Index Excess Return (the "Index") is designed to reflect the returns that are potentially available through an unleveraged investment in short-term futures contracts on the CBOE Volatility Index®. The Index offers exposure to a daily rolling long position in the first and second month VIX Index futures contracts and reflects the implied volatility of the S&P 500® at various points along the volatility forward curve.

XXV product page no longer available (previously at http://www.ipathetn.com/US/16/en/details.app?instrumentId=68522)

Provider website: https://ipathetn.barclays/

XXV Quotes, Assets, and Trading Volume

Yahoo Finance: finance.yahoo.com/quote/XXV

Bloomberg.com: www.bloomberg.com/quote/XXV:US

By remaining on this website or using its content, you confirm that you have read and agree with the Terms of Use Agreement.

We are not liable for any damages resulting from using this website. Any information may be inaccurate or incomplete. See full Limitation of Liability.

Content may include affiliate links, which means we may earn commission if you buy on the linked website. See full Affiliate and Referral Disclosure.

We use cookies and similar technology to improve user experience and analyze traffic. See full Cookie Policy.

See also Privacy Policy on how we collect and handle user data.

© 2024 Macroption